| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |